Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07829445) titled 'PRECISE LBCL: Precision Treatment Readiness Through Comprehensive Genomic Sequencing in 1st Line LBCL' on Sept. 17.

Study Type: Observational

Primary Sponsor: M.D. Anderson Cancer Center

Condition: LBCL Comprehensive Genomic Precision Treatment

Intervention: Other: Standard of Care (SOC)

Recruitment Status: Not recruiting

Date of First Enrollment: February 25, 2027

Target Sample Size: 60

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07829445

Published by HT Digital Content Services with permission from Health Daily Digest....